Overview

Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil

Status:
Completed
Trial end date:
2018-08-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and compare the Pharmacokinetics (PK) of concomitant administration of Padsevonil (PSL) in the presence and absence of erythromycin in healthy study participants.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
Treatments:
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate